Mag. Pharm. Dr. Karin Schaupp

  • * 1950 - Fohnsdorf, Steiermark, Austria

Education

  • 1967-1968:Foreign exchange student with American Field Service in
    USA, Graduation from Englewood High School, Colorado
  • 1969: Graduation in Graz
  • 1976: Master of Pharm.Science (Mag.Pharm) at the University of Graz
  • 1978: PhD from the University of Graz, Assistant Professor at the Inst. of Pharm. Science
  • 2014: Professorship for Applied Corporate Leadership at the Karl-FranzensUniversity of Graz

Profession

  • 1980: Head of Analytical Department and Quality Assurance at Leopold Pharma
  • 1985: Director of R&D at Leopold Pharma
  • 1987: Director of R&D for the Knoll Hospital group (A,D,F,NL)
  • 1992: Acquisition of the Knoll Hospital group by Fresenius AG,D: Director of R&D
  • 1995: "Finance for Executives" Programs at
    INSEAD/Fountainebleau
  • 1997: General Manager Fresenius Kabi Austria
  • 1999: Vice-president for the Region Austria /SE Europe for a Business Unit
  • 2000: Member of the Board of Fresenius Kabi AG, Bad Homburg, D with worldwide Business responsibility including R&D and Productions
  • 2001: Nomination "Generalbevollmächtigte" of Fresenius Kabi
    AG
  • Seit 2003: Independent Consultant for Strategic Development and Innovation Transfer
    Organizational Structures Mergers and Acquisitions

Mandates

  • Member of the Scientific Advisory Board of the "JOANNEUM RESEARCH ForschungsGesmbH"
  • Member of the Supervisory Board of the Competence Center
    "Pharmaceutical Engineering " GmbH
  • Member of the Supervisory Board of the Österreichische Salinen Aktiengesellschaft und Salinen Austria Aktiengesellschaft

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

AT&S Austria Technologie & Systemtechnik AG published this content on 12 June 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 June 2024 16:32:05 UTC.